CARDIOTECH RECEIVES ETHICS COMMITTEE APPROVAL FOR CARDIOPASS EUROPEAN CLINICAL TRIAL

CardioTech International, a developer and manufacturer of advanced medical device materials and products for the treatment of cardiovascular and other diseases, Oct. 10 reported that it has received the necessary approval from the Ethics Committee of the European medical center where preparations are underway for a clinical trial of CardioPass, the Company's proprietary synthetic coronary bypass graft. Patient enrollment is scheduled to begin at the end of calendar 2006.

Yahoo (http://biz.yahoo.com/prnews/061010/netu038.html?.v=55)